If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFDM Group Regulatory News (FDM)

Share Price Information for FDM Group (FDM)

Share Price is delayed by 15 minutes
Get Live Data
106.60    0.00 (0.00%)
Bid:
105.00
Ask:
106.20
Spread: 1.20 (1.143%)
Market Cap: £116.56m
FDM Live PriceLast checked at - London Stock Exchange

Intraday FDM Group Share Chart

Director/PDMR Shareholding

4 Jun 2018 15:14

RNS Number : 2355Q
FDM Group (Holdings) plc
04 June 2018
Β 

4 June 2018

FDM Group (Holdings) plc

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

PSP Award - 1 June 2018

On 1 June 2018 FDM Group (Holdings) plc ("FDM") granted awards over ordinary shares in the Company under the FDM 2014 Performance Share Plan (the "PSP"), as noted below.

The vesting of the awards is subject to the achievement of a performance condition based upon the annual compound growth in FDM's earnings per share over the three-year performance period commencing with FDM's 2018 financial year. Ordinarily, the awards and options will vest (subject to the achievement of the performance condition) following the announcement of FDM's results for its 2020 financial year.

Other than in the case of Jonathan Young, the awards have been structured as "Approved PSP" ("APSP") awards to take account of potential tax advantages for the participants and FDM. Each APSP award consists of a tax qualifying option under the FDM Company Share Option Plan (the "CSOP") over shares with a value of up to Β£30,000 and with an exercise price of Β£10.21 per share, a "Linked Award" under the PSP which is principally a funding award to fund the exercise price of the CSOP option and a separate award under the PSP in respect of the balance of the value of the award above Β£30,000, as noted below.

Jonathan Young is not eligible to receive an award under the CSOP and, accordingly, has received only an award under the PSP

Each award (including the Linked Awards) under the PSP has been granted in the form of an option with an exercise price per share of Β£0.01.Β 

Name

Number of shares subject to PSP award

Number of shares subject to CSOP option

Maximum number of shares subject to Linked Award*

Executive Directors

Rod Flavell

15,562

2,938

2,938

Sheila Flavell

15,562

2,938

2,938

Andy Brown

15,562

2,938

2,938

Mike McLaren

15,562

2,938

2,938

Other Senior Managers

Jonathan Young

18,500

N/A

N/A

Stewart Sharman

4,312

2,938

2,938

Β 

*Each Linked Award is principally to fund the exercise price of the CSOP option. If the CSOP option is exercised at a gain, the Linked Award will be exercisable over such number of shares as have a market value at the date of exercise equal to the aggregate exercise price of the CSOP option. If the CSOP option is not capable of exercise at a gain and is released, the Linked Award may be exercised in respect of the number of shares in respect of which it vests.

Β 

The notification below, made pursuant to Article 19 of Regulation (EU) No 596/2014 on Market Abuse, provides further information about these transactions.

1

Details of the person discharging managerial responsibilities / person closely associated

Β 

(a)

Name

(i) Rod Flavell

(ii) Sheila Flavell

(iii) Andy Brown

(iv) Mike McLaren

(v) Jonathan Young

(vi) Stewart Sharman

Β 

2

Reason for the notification

Β 

(a)

Position/Status

(i) Chief Executive Officer

(ii) Chief Operating Officer

(iii) Chief Commercial Officer

(iv) Chief Financial Officer

(v) Chief Information Officer

(vi) Senior Manager

Β 

(b)

Initial notification / Amendment

Initial notification

Β 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

(a)

Name

FDM Group (Holdings) Plc

Β 

(b)

LEI

213800YR62D7GUZLMZ71

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

(a)

Description of the financial instrument, type of instrument

Β 

Identification Code

Β 

Ordinary shares of Β£0.01

Β 

Β 

ISIN: GB00BLWDVP51

(b)

Nature of the transaction

Β 

Grant of awards over ordinary shares

Β 

(c)

Price(s) and volume(s)

Β 

Name

Price

Number of ordinary shares subject to PSP award

Number of ordinary shares subject to CSOP option

Maximum number of ordinary shares subject to Linked Award

Rod Flavell

Nil

15,562

2,938

2,938

Sheila Flavell

Nil

15,562

2,938

2,938

Andy Brown

Nil

15,562

2,938

2,938

Mike McLaren

Nil

15,562

2,938

2,938

Jonathan Young

Nil

18,500

N/A

N/A

Stewart Sharman

Nil

4,312

2,938

2,938

Β 

(d)

Aggregated Information

- Aggregated Volume

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

- Price

Β 

Name

Number of ordinary shares subject to awards in total

Rod Flavell

21,438

Sheila Flavell

21,438

Andy Brown

21,438

Mike McLaren

21,438

Jonathan Young

18,500

Stewart Sharman

10,188

Β 

Β 

Β 

N/A

(e)

Date of the Transaction

1 June 2018

Β 

(f)

Place of the Transaction

Outside a trading venue

Β 

Name of authorised official of issuer responsible for making notification:

Mark Heather, Company Secretary, FDM Group (Holdings) Plc

Β 

Enquiries:

FDM

Mike McLaren - Chief Financial Officer

0203 056 8240

Weber Shandwick

Nick Oborne / Tom Jenkins

020 7067 0000

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHEALKLEFFPEFF
Date   Source Headline
19th Aug 20159:17 amRNSHolding(s) in Company
14th Aug 20152:17 pmRNSDirector/PDMR Shareholding
11th Aug 201512:15 pmRNSDirector/PDMR Shareholding
29th Jul 20157:00 amRNSHalf Yearly Report
1st May 20159:46 amRNSHolding(s) in Company
30th Apr 20151:02 pmRNSAGM Statement
30th Apr 20157:00 amRNSAGM Statement and Dividend Declaration
21st Apr 20151:44 pmRNSDirector/PDMR Shareholding
20th Apr 20158:23 amRNSHolding(s) in Company
11th Mar 20157:00 amRNSFinal Results
18th Feb 20157:00 amRNSNotice of Results
23rd Oct 20147:00 amRNSInterim Management Statement
22nd Sep 201411:27 amRNSHolding(s) in Company
19th Sep 20148:59 amRNSTotal Voting Rights
30th Jul 20147:00 amRNSInterim Results
7th Jul 20143:25 pmRNSHolding(s) in Company
23rd Jun 20145:24 pmRNSHolding(s) in Company
23rd Jun 20142:40 pmRNSHolding(s) in Company
20th Jun 20141:43 pmRNSDirector Declaration
20th Jun 20148:00 amRNSAdmission to trading on the London Stock Exchange
19th May 20117:00 amRNSDoc re. 8-K
11th May 20112:57 pmRNSDoc re. 10-Q
4th May 20117:00 amRNSDoc re. 8-K
28th Apr 201112:39 pmRNSCancellation of admission and listing
26th Apr 20112:13 pmRNSDoc re. 8-K
26th Apr 20111:05 pmRNS1st Quarter Results
13th Apr 20114:46 pmRNSDoc re. 8-K
4th Apr 20112:57 pmRNSDoc re. 8-K
2nd Mar 20117:00 amRNSDoc re. 8-K
28th Feb 20113:18 pmRNSDoc re. 8-K
11th Feb 20117:00 amRNSFord to Reduce Debt By an Additional $3 Billion
2nd Feb 20117:00 amRNSDoc re. 8-K
28th Jan 20114:59 pmRNSDoc re. 8-K
28th Jan 201112:47 pmRNS4th Quarter Results
5th Jan 20112:29 pmRNSDoc re. 8-K
2nd Dec 20102:57 pmRNSDoc re. 8-K
25th Nov 20107:00 amRNSResults of Conversion Offers
18th Nov 20105:22 pmRNSDoc re. 8-K
9th Nov 20107:00 amRNSDoc re. 10-Q
4th Nov 20107:00 amRNSDoc re. 8-K
26th Oct 20102:53 pmRNSDoc re. 8-K
26th Oct 20102:53 pmRNSDoc re. 8-K
26th Oct 20101:15 pmRNSLaunch of Conversion Offers
26th Oct 20101:15 pmRNSLaunch of Conversion Offers
26th Oct 201012:57 pmRNS3rd Quarter Results
26th Oct 201012:57 pmRNS3rd Quarter Results
4th Oct 20106:25 pmRNS8-K
2nd Sep 20102:17 pmRNSDoc re. 8-K
10th Aug 20107:00 amRNS10-Q
4th Aug 20102:11 pmRNSDoc re. 8-K

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.